AU2001260445A1 - Triterpenoid derivatives - Google Patents
Triterpenoid derivativesInfo
- Publication number
- AU2001260445A1 AU2001260445A1 AU2001260445A AU6044501A AU2001260445A1 AU 2001260445 A1 AU2001260445 A1 AU 2001260445A1 AU 2001260445 A AU2001260445 A AU 2001260445A AU 6044501 A AU6044501 A AU 6044501A AU 2001260445 A1 AU2001260445 A1 AU 2001260445A1
- Authority
- AU
- Australia
- Prior art keywords
- compound
- formula
- relates
- present
- triterpenoid derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000003648 triterpenes Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000021736 acetylation Effects 0.000 abstract 1
- 238000006640 acetylation reaction Methods 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000032839 leukemia Diseases 0.000 abstract 1
- 230000026731 phosphorylation Effects 0.000 abstract 1
- 238000006366 phosphorylation reaction Methods 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present invention relates to the use of a compound of formula (I), or a pharmaceutically acceptable salt thereof, in therapy. Prefereably, the compound may be used for treating a patient suffering from leukaemia, cancer or other proliferative disorder. A further embodiment relates to the use of a compound of formula (I) in an assay for detecting the phosphorylation and acetylation state of cellular substrates. The present invention also relates to novel compounds of formula (Ia).
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0012526.0 | 2000-05-23 | ||
| GB0012526A GB2362648A (en) | 2000-05-23 | 2000-05-23 | Triterpenoid derivatives |
| PCT/GB2001/002313 WO2001090136A2 (en) | 2000-05-23 | 2001-05-23 | Triterpenoid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001260445A1 true AU2001260445A1 (en) | 2001-12-03 |
Family
ID=9892207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001260445A Abandoned AU2001260445A1 (en) | 2000-05-23 | 2001-05-23 | Triterpenoid derivatives |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7041701B2 (en) |
| EP (1) | EP1294370B1 (en) |
| AT (1) | ATE305776T1 (en) |
| AU (1) | AU2001260445A1 (en) |
| DE (1) | DE60113838T2 (en) |
| ES (1) | ES2250406T3 (en) |
| GB (1) | GB2362648A (en) |
| WO (1) | WO2001090136A2 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0012528D0 (en) * | 2000-05-23 | 2000-07-12 | Univ Palackeho | Triterpenoid derivatives |
| US6720445B2 (en) | 2000-12-21 | 2004-04-13 | Beacon Laboratories, Inc. | Acetyloxymethyl esters and methods for using the same |
| GB0128071D0 (en) * | 2001-11-22 | 2002-01-16 | Cyclacel Ltd | Medicament |
| JPWO2003057224A1 (en) * | 2001-12-28 | 2005-08-25 | 日清オイリオグループ株式会社 | Apoptosis inducer |
| EP2269998A3 (en) | 2004-08-19 | 2011-03-30 | DSM IP Assets B.V. | Process for the rectification of mixtures of high-boiling air- and/or temperature-sensitive useful products |
| GB0419416D0 (en) * | 2004-09-01 | 2004-10-06 | Inst Of Ex Botany Ascr | 4-Arylazo-3,5-Diamino-Pyrazole compounds and use thereof |
| CZ300722B6 (en) * | 2006-09-27 | 2009-07-22 | Univerzita Karlova v Praze, Prírodovedecká fakulta | Process for preparing inclusion complex of pentacyclic and tetracyclic terpenoids, process for preparing pharmaceutical composition containing this inclusion complex, inclusion complex of pentacyclic or tetracyclic terpenoid and pharmaceutical compos |
| US9012439B2 (en) * | 2007-10-29 | 2015-04-21 | University Of Rochester | Use of electrophilic compounds for inducing platelet production or maintaining platelet function |
| JP5320530B2 (en) * | 2008-02-14 | 2013-10-23 | 秋田県 | Triterpene compound useful as anticancer agent and anticancer composition using the triterpene compound |
| CZ2008528A3 (en) * | 2008-09-01 | 2009-11-18 | Univerzita Karlova v Praze, Prírodovedecká fakulta | Triterpenoid derivatives for treating tumor diseases and pharmaceutical composition in which the derivatives are comprised |
| CZ301318B6 (en) | 2008-11-13 | 2010-01-13 | Univerzita Palackého v Olomouci | 2-Deoxyglycosides of triterpenoids, process of their preparation and their use as medicament |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2810758A (en) * | 1955-05-26 | 1957-10-22 | Wisconsin Alumni Res Found | Steroid and intermediate compounds |
| CH602794A5 (en) * | 1974-10-29 | 1978-08-15 | Hoffmann La Roche | |
| IL50854A (en) * | 1975-11-11 | 1979-12-30 | Sparamedica Ag | D-homosteroids their manufacture and pharmaceutical compositions containing them |
| US5869535A (en) * | 1995-03-21 | 1999-02-09 | The Board Of Trustees Of The University Of Illinois | Method and composition for selectively inhibiting melanoma |
| US6048847A (en) * | 1997-09-30 | 2000-04-11 | Dabur Research Foundation | Use of betulinic acid and its derivatives for inhibiting cancer growth and a method of monitoring this |
-
2000
- 2000-05-23 GB GB0012526A patent/GB2362648A/en not_active Withdrawn
-
2001
- 2001-05-23 DE DE60113838T patent/DE60113838T2/en not_active Expired - Lifetime
- 2001-05-23 US US10/296,457 patent/US7041701B2/en not_active Expired - Fee Related
- 2001-05-23 EP EP01934139A patent/EP1294370B1/en not_active Expired - Lifetime
- 2001-05-23 ES ES01934139T patent/ES2250406T3/en not_active Expired - Lifetime
- 2001-05-23 WO PCT/GB2001/002313 patent/WO2001090136A2/en not_active Ceased
- 2001-05-23 AT AT01934139T patent/ATE305776T1/en not_active IP Right Cessation
- 2001-05-23 AU AU2001260445A patent/AU2001260445A1/en not_active Abandoned
-
2006
- 2006-03-17 US US11/378,228 patent/US7749988B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| GB0012526D0 (en) | 2000-07-12 |
| EP1294370A2 (en) | 2003-03-26 |
| ATE305776T1 (en) | 2005-10-15 |
| WO2001090136A3 (en) | 2003-01-16 |
| EP1294370B1 (en) | 2005-10-05 |
| US20060160890A1 (en) | 2006-07-20 |
| US20040266868A1 (en) | 2004-12-30 |
| DE60113838D1 (en) | 2006-02-16 |
| ES2250406T3 (en) | 2006-04-16 |
| US7041701B2 (en) | 2006-05-09 |
| WO2001090136A2 (en) | 2001-11-29 |
| US7749988B2 (en) | 2010-07-06 |
| GB2362648A (en) | 2001-11-28 |
| DE60113838T2 (en) | 2006-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY141739A (en) | Substituted quinazoline derivatives as inhibitors of aurora kinases | |
| MXPA03010961A (en) | Thiazole compounds useful as inhibitors of protein kinases. | |
| WO2001044247A3 (en) | Agents and methods for the treatment of proliferative diseases | |
| PL353539A1 (en) | N-heterocyclic derivatives as NOS inhibitors | |
| IL157816A0 (en) | Steroids as agonists for fxr | |
| PT1200412E (en) | IMIDAZOLE ANTI-PROLIFERATIVE AGENTS | |
| PL367682A1 (en) | Dolastatin 10 derivatives | |
| MXPA03008623A (en) | Pharmaceutical combinations for the treatment of cancer. | |
| AU2001260445A1 (en) | Triterpenoid derivatives | |
| AU2001260880A1 (en) | Pharmaceutical compounds for treating copd | |
| DK1678162T3 (en) | Β-glycoprotein inhibitor, process for its preparation and pharmaceutical composition comprising it | |
| AU2002352708A1 (en) | Cytotoxic agents | |
| AU2001263278A1 (en) | Cyclic gmp-specific phosphodiesterase inhibitors | |
| SE1212311T3 (en) | ||
| MXPA04005809A (en) | Protein kinase inhibitors. | |
| TR200102514T2 (en) | Method for COPD treatment | |
| AU2001296699A1 (en) | Condensed pyrazindione derivatives as pde inhibitors | |
| AU2002248531A1 (en) | Pyrazolopyriadine derivatives | |
| AU3919001A (en) | Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers | |
| GB0015444D0 (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors | |
| AU2001258631A1 (en) | Triterpenoid derivatives | |
| AU2576901A (en) | Agents and methods for the treatment of proliferative diseases | |
| WO2002098399A3 (en) | Cancer treatment method and compositions comprising compounds of the ginger family | |
| ZA200400824B (en) | Pyridin-2-yl-methlyamine derivatives for treating opioid dependence. | |
| DK1572715T3 (en) | Steroid compounds with antitumor activity |